Viewing Study NCT01236560


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-02-10 @ 4:01 AM
Study NCT ID: NCT01236560
Status: COMPLETED
Last Update Posted: 2024-02-20
First Post: 2010-11-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
Sponsor:
Organization: